Cabaletta Bio, Inc.

General ticker "CABA" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $338.4M (TTM average)

Cabaletta Bio, Inc. follows the US Stock Market performance with the rate: 7.2%.

Estimated limits based on current volatility of 6.3%: low 1.00$, high 1.14$

Factors to consider:

  • Total employees count: 156 (-4.9%) as of 2025
  • Company does not operate outside North America (retrieved using AI)
  • Top business risk factors: Commercialization failure, Regulatory and compliance, Manufacturing scale up, Clinical trial failure, Inability to raise capital
  • Current price 24.6% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [1.34$, 3.74$]
  • 2026-12-31 to 2027-12-31 estimated range: [1.42$, 3.82$]

Financial Metrics affecting the CABA estimates:

  • Negative: with PPE of -1.0 at the end of fiscal year the price was high
  • Negative: negative Operating income
  • Positive: -39.19 < Investing cash flow per share per price, % of -22.10
  • Positive: Inventory ratio change, % of 0 <= 0
  • Negative: negative Net income
  • Negative: negative Operating cash flow

Similar symbols

Short-term CABA quotes

Long-term CABA plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $74.66MM $125.14MM $172.24MM
Operating Income $-74.66MM $-125.14MM $-172.24MM
Non-Operating Income $6.99MM $9.28MM $4.38MM
Interest Expense $0.00MM $0.75MM $2.00MM
R&D Expense $55.42MM $97.20MM $142.67MM
Income(Loss) $-67.67MM $-115.86MM $-167.86MM
Net Income(Loss)* $-67.67MM $-115.86MM $-167.86MM
Stockholders Equity $236.20MM $152.34MM $112.05MM
Assets $253.65MM $185.05MM $165.08MM
Operating Cash Flow $-53.55MM $-88.22MM $-131.08MM
Capital expenditure $0.69MM $2.21MM $1.23MM
Investing Cash Flow $-22.45MM $47.29MM $-50.27MM
Financing Cash Flow $187.63MM $11.68MM $100.35MM
Earnings Per Share** $-1.65 $-2.34 $-1.64

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.